conditions of the tumour to confirm the pathological diagnosis. 8, 9 Unfortunately, cystoscopy is an invasive diagnostic procedure, and its use is limited by the lack of suitable biomarkers for pathological staining. Currently, the identification of new markers is of substantial importance for enabling an early diagnosis of BC. 10, 11 Although a number of molecules related to BC have been described in the literature, such as forkhead box M1 (FOXM1), collagen type V alpha 2 chain (COL5A2) and N-myc, there are still no effective molecular targets for clinical diagnosis and therapy. 12, 13 Thus, more specific and sensitive biomarkers and therapeutic targets need to be identified to improve the early diagnosis and prognosis of BC patients.
It is well known that the biological and molecular expression profiles of tumour cells are similar to those of embryonic cells but differ greatly from those of normal adult cells. 15 Therefore, an increasing number of studies have been devoted to studying the molecular differences between normal adult and embryonic cells to identify targets, such as alpha fetoprotein (AFP), for the diagnosis and treatment of malignant cells. 16 As a member of the proline and acidic amino acid-rich (PAR) subfamily of basic region/leucine zipper (bZIP) transcription factors, which also includes albumin D box-binding protein (DBP), human hepatic leucemia factor (HLF) and chicken vitellogenin gene-binding protein (VBP), Thyrotroph embryonic factor (TEF) is expressed in a broad range of cells and tissues in adult animals. 17, 18 TEF expression appears to be restricted to the developing anterior pituitary gland during embryonic development. 20 In normal cells, TEF is an apoptotic regulator of hematopoietic progenitors and controls hematopoietic cell proliferation. 21 In mouse fibroblasts, TEF has been reported to control actin distribution and cell shape. 22 Furthermore, TEF has been reported to be involved in the development of various human diseases. For example, a study including 408 subjects using a linear regression model showed that TEF is associated with the Hamilton Rating Scale for Depression (HAMD) scores in patients with Parkinson's disease after adjusting for clinical variables. 23 Using multivariate generalized linear models, the association between TEF and depressive symptoms further confirmed that TEF is closely related to the development of human disease. 24 However, the role of TEF in malignant processes is still unknown.
In the present study, we demonstrate that TEF mRNA and protein expression are downregulated in BC cells and human BC tissues.
Overexpressed TEF significantly inhibits the G1/S transition in the cell cycle as well as tumorigenesis via regulating the AKT/FOXOs signalling pathway. In addition, opposite results were observed in TEF-silenced cells. These results suggest a potential role for TEF as a diagnostic marker and a valuable therapeutic target in BC.
| MATERIAL S AND ME THODS

| Microarray data processing and visualization
The RNA sequencing V2 profile dataset was downloaded on November 29th, 2014 from the Cancer Genome Atlas (TCGA) and contained 408 BC tissue and 19 adjacent normal bladder tissue samples. Profile data extractions were performed using Excel and MeV 4.9 (http://www.tm4.org/mev), and Gene Set Enrichment Analysis (GSEA) was performed using gsea 2.2.1 (http://www.broadinstitute.
org/gsea).
| Statistical analysis
spss version 13.0 (SPSS Inc, Chicago, IL) was used in all statistical analyses. 25 The associations between the TEF RNA level and the clinicopathological characteristics of the TCGA data were analysed using the Chi-squared test. Survival curves were plotted using the Kaplan-Meier method and compared using the log-rank test. A twotailed P-value of <0.05 was considered statistically significant in all tests. 
| Cell lines and tissues
| RNA extraction and real-time quantitative PCR
Total RNA was extracted from BC cells, fresh tissues and the stably constructed cell lines using TRIzol reagent (Invitrogen Life Technologies)
according to the manufacturer's instructions. The RNA was then reverse transcribed and subjected to real-time quantitative PCR (RTqPCR) as previously described. 26 RT-qPCR was performed using the Biosystems 7500 Sequence Detection system. The primers used were as follows: TEF (forward, 5′-CTGCCTCACAACGACTCCTTTCTCT-3′;
reverse, 5′-TCGCCTCTGTCTCCTCTTCACCATAG-3′); p21 Cip1 (forward, 5′-CGATGCCAACCTCCTCAACGA-3′; reverse, 5′-TCGCAGACCTCCA GCATCCA-3′); p27 Kip1 (forward, 5′-TGCAACCGACGATTCTTCTAC   TCAA-3′; reverse, 5′-CAAGCAGTGATGTATCTGATAAACAAGGA-3′) and GAPDH (forward, 5′-ACCACAGTCCATGCCATCAC-3′; reverse, 5′-TCCACCACCCTGTTGCTGTA-3′). Expression data were normalized to the geometric mean of the housekeeping gene GAPDH to control for variability in the expression levels.
| Western blot analysis
Western blot analysis was performed according to standard methods as previously described. 
| Vectors and retroviral infection
The TEF expression construct was generated by subcloning PCR-amplified full-length human TEF cDNA into the pMSCV- in triplicate and allowed to attach and grow for 24 hour. 26 At each time point, groups of cells were incubated with 100 μL of 0.5 mg/ mL sterile MTT for 4 hour at 37°C. Then, the culture medium was removed, and 150 μL of DMSO (Sigma) was added. After shaking for 10 minute, the absorbance values were measured at 490 nm as the reference wavelength. 
| Flow cytometry analysis
| Colony formation assay
Colony formation assays reflect cell proliferation according to the number of clones formed by adherent cells. As previously described, 1000 cells/well were incubated in 6-well plates. All stable cell lines were included in the colony formation assay. 26 Ten days later, the colonies were fixed with 10% formaldehyde for 5 minute and then stained with 1.0% crystal violet for 30 seconds. All experiments were performed in triplicate for each cell line.
| Anchorage-independent growth assay
A soft agar, anchorage-independent growth assay was used to determine the growth ability of malignant cells as a suspension. As previously described, 500 cells/well (RT4-Vector1, RT4-TEF, RT4-vector2, RT4-RNAi1, HT1376-Vector1, HT1376-TEF, HT1376-vector2, HT-1376-RNAi1) were seeded in 2 mL of complete medium plus 0.3% agar (Sigma) for 12 days. 26 All experiments were performed in triplicate for each cell line.
| Bromodeoxyuridine labelling and immunofluorescence assay
Bromodeoxyuridine (BrdU) can be incorporated into the newly synthesized DNA of cells during the S phase and is commonly used to Figure 1C ). Meanwhile, the mRNA level of TEF was also downregulated in five fresh BC tissues (T) compared to that in the paired adjacent normal tissue (ANT; Figure 1E ). Western blot analysis revealed that TEF protein expression was also downregulated in malignant BC cells (or tissues) compared to that in non-malignant cells (or tissues, Figure 1D ,F). Taken together, these results strongly indicate that TEF is downregulated in human BC.
To investigate the significance of TEF downregulation in BC, data from the TCGA were categorized and analysed in depth. Using the mean value as a cut-off, all 400 patients with clinical staging data were categorized into one of two groups based on the TEF RNA level in their tumours: a high TEF RNA group and a low TEF RNA group. As shown in Figure 1G , the RNA expression of TEF was higher in early-stage tumours (stages I-II) and was lower in advanced-stage tumours (stages III-IV, P < 0.01). Kaplan-Meier survival curves were plotted for the 294 patients with available survival data, and the results showed that the overall survival of patients with low TEF RNA level was significantly shorter than that of patients with high TEF RNA level ( Figure 1H , P = 0.016).
Collectively, these results indicate that downregulation of TEF in BC patients correlates with poor survival.
| TEF regulates the proliferation of BC cells
Gene set enrichment analysis was used to explore the role of TEF 
| TEF modulates the tumorigenesis of BC
As shown in Figure 3A ,B, the colony number was significantly de- Figure 3F ). After tumour imaging, the larger part of each final xenograft tumour was paraffin-embedded, sliced and stained. As shown in Figure 3G , the protein level of Ki67 was low in samples Taken together, these results suggest that TEF plays an important role in the tumorigenicity of BC cells.
| TEF arrests the cell cycle G1/S transition in BC cells
Gene set enrichment analysis also revealed that the mechanism responsible for the anti-proliferative effects of TEF involves the G1/S Figure 4B ). As shown in the representative images of Figure 4C and the statistical diagram in Figure 4D , the percentage of BrdU-incorporated cells dramatically decreased upon overexpressing TEF but significantly increased upon silencing TEF. These results clearly show that TEF blocks the G1/S transition of the cell cycle in BC cells.
To further investigate the biological function of TEF in arresting the cell cycle, genes closely related to the G1/S transition were examined by Western blot. As shown in Figure 4E , the protein expression levels of the cell cycle promoter cyclin D1, CDK4 and CDK6
were downregulated in TEF-overexpressing cells and upregulated in TEF-silenced cells. Conversely, the p21 Cip1 and p27 Kip1 protein expression levels were increased in TEF-overexpressing cells but decreased in TEF-silenced cells ( Figure 4E ). Moreover, RT-qPCR analysis verified that the mRNA expression of p21 Cip1 and p27 Kip1 was increased in TEF-overexpressing cells but decreased in TEF-silenced cells ( Figure 4F ).
| TEF regulates AKT/FOXOs signalling
Gene set enrichment analysis was also used to explore which intracellular signalling pathway(s) might be involved in TEF-mediated biological processes. As shown in Figure 5A , the TEF RNA level negatively 
| D ISCUSS I ON
Many transcription factors play key roles in cellular differentiation and the delineation of cell phenotypes. 32 Hunger et al 33 found that ). Clearly, the expression of FOXOs closely correlates with the clinicopathological characteristics and prognosis of various cancers and plays important roles in almost all types of tumours. 38, 39 In diffuse large B-cell lymphoma, FOXO4
protein is related to stem cell-like properties and resistance to treatment. 41 In clear-cell renal carcinoma cells, overexpression of FOXO4 induces cellular apoptosis. 42 In BC, FOXO1 protein was reported to mediate cell apoptosis. 43 Other biological events, such as autophagic flux, oxidative stress, self-renewal, migration and invasion,
were also demonstrated to be regulated by FOXOs. 44, 45 However, mechanistic studies on FOXOs are rare and tend to focus on several key biological molecules, among which the most well-characterized and important is the Ser and Thr kinase AKT (also known as protein kinase B, PKB). 48 One direct piece of mechanistic evidence is that
FOXOs protein phosphorylation is enhanced in the growth plates of AKT transgenic mice. 49 FOXO transcriptional effectiveness is largely determined by phosphorylation-dependent nucleocytoplasmic shuttling. 50 AKT phosphorylates FOXOs, which leads to their translocation to the cytoplasm, thereby promoting the proliferation of malignant cells. 51 This research shows that the phosphorylation 
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